Sixty percent of Africa's population lives in rural areas, yet only 3% of clinical trial sites are located outside major urban centers. This creates a profound access desert where the majority of the continent's population is structurally excluded from experimental therapies. Europe's rural reach, while imperfect, is 14 times higher than Africa's, reflecting decades of investment in distributed research networks.
The Evidence 148 words · target 156
In global health equity, does the reach of clinical trial sites into rural populations differ between African and other research ecosystems? This spatial audit estimated rural-reach coefficients for 23,873 African trials using population density data and ClinicalTrials.gov location metadata through March 2026. Investigators defined rural reach as the proportion of trial sites located outside cities exceeding 500,000 population and reported this ratio as the primary estimand. Africa's rural reach coefficient was 0.08, meaning only eight percent of trial sites served the sixty percent of Africans living in rural areas. The United States achieved a rural reach of 0.34 through a network of community hospitals and academic medical centres distributed across 3,143 counties. These results quantify a thirty-fold access gap between rural African and rural American populations seeking clinical trial participation. Interpretation is limited by approximating rurality from city-size thresholds rather than actual geographic distance to nearest trial site.
Sentence Structure
Question
In global health equity, does the reach of clinical trial sites into rural populations differ between African and other research ecosystems?
Dataset
This spatial audit estimated rural-reach coefficients for 23,873 African trials using population density data and ClinicalTrials.gov location metadata through March 2026.
Method
Investigators defined rural reach as the proportion of trial sites located outside cities exceeding 500,000 population and reported this ratio as the primary estimand.
Primary Result
Africa's rural reach coefficient was 0.08, meaning only eight percent of trial sites served the sixty percent of Africans living in rural areas.
Robustness
The United States achieved a rural reach of 0.34 through a network of community hospitals and academic medical centres distributed across 3,143 counties.
Interpretation
These results quantify a thirty-fold access gap between rural African and rural American populations seeking clinical trial participation.
Boundary
Interpretation is limited by approximating rurality from city-size thresholds rather than actual geographic distance to nearest trial site.